According to Coherent Market Insights "The global immunomodulators market is estimated to be valued at US$ 91850.0 Million in 2021 and is expected to reach US$ 156378.2million by 2028, at a CAGR of 7.9% during the forecast period (2021–2028)".
Immunomodulators are used all over the world, especially in regions such as the US, UK, and Italy. Several different types of immunomodulators exist. The most common are IL-6 inhibitors, BTK inhibitors, and JAK inhibitors. Immunomodulators suppress or stimulate the immune response. They are categorized into three groups: type I, type II, and Type III. The former affects the immune system in a normal state, while the latter has a compromised or weakened immune system. In some cases, they can even have an anti-tumor effect. In this case, the patient may not even be aware of the drug. Nevertheless, this is a promising avenue for further research.
Some of these immunomodulators are also known as adaptogens. These agents are used to protect the body from stressors, including infections and tumors. Rasayanas are plants that have been shown to contain immunomodulatory activity. Mangifera indica, Tinospora cordifolia, and Withania somnifera have all been shown to improve the host immune response to tumors and infection. Although the mechanism of these compounds is unknown, this treatment has shown promising results in some patients.
These immunomodulators are effective in combating infections and cancer. Infections are also a prime candidate for these immunomodulators. They are also used to treat certain conditions, such as pyoderma gangrenosum. The two main types of immunomodulators are azathioprine and tacrolimus. These drugs are taken orally. However, patients with severe diarrhea, vomiting, and fever should consult a physician before stopping these medications. In regions, such as the United States, the increasing prevalence of multiple myeloma has increased the usage of immunomodulators. For instance, according to the American Cancer Society, there are currently around 34,920 new cases of multiple myeloma in the U.S.
There are many differences between immunosuppressive and immunomodulators. Both can suppress or stimulate the immune response. The type of drug you use depends on the type of condition. Some of the most commonly prescribed ones suppress the immune system. Some of these drugs are nonspecific, so they will not have an effect on the body. As with other types of antivirals, immunomodulators are categorized into two main categories: specific and nonspecific. These two categories have different functions and are based on the type of immune response that the drugs have on their targets. Those that suppress the immune system are considered nonspecific.